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Objectives. The Asymptomatic Cardiac Ischemia Pilot (ACIP) 
study showed that revascularization is more effective than medical 
therapy in suppressing cardiac ischemia t 12 weeks. This report 
compares the relative fficacy of coronary angioplasty or coronary 
artery bypass graft surgery in suppressing ambulatory electrocar- 
diographic (ECG) and treadmill exercise cardiac ischemia be- 
tween 2 and 3 months after evascularization in the ACIP study. 
Background. Previous tudies have shown that coronary angio- 
plasty and bypass urgery relieve angina early after the procedure 
in a high proportion of selected patients. However, alleviation of 
ischemia on the ambulatory ECG and treadmill exercise test have 
not been adequately studied prospectively after evascularization. 
Methods. In patients randomly assigned to revascularization in 
the ACIP study, the choice of coronary angioplasty or bypass 
surgery was made by the clinical unit staff' and the patient. 
Results. Patients assigned to bypass urgery (n = 78) had more 
severe coronary disease (p = 0.001) and more ischemic episodes 
(p = 0.01) at baseline than those assigned to angioplasty (n = 92). 
Ambulatory ECG ischemia was no longer present 8 weeks after 
revascularization (12 weeks after enrollment) in70% of the bypass 
surgery group versus 46% of the angioplasty group (p = 0.002). ST 
segment depression on the exercise ECG was no longer present in 
46% of the bypass urgery group versus 23% of the angioplasty 
group (p = 0.005). Total exercise time in minutes on the treadmill 
exercise test increased by 2.4 rain after bypass urgery and by 
1.4 rain after angioplasty (p = 0.02). Only 10% of the bypass 
surgery group versus 32% of the angioplasty group still reported 
angina in the 4 weeks before the 12-week visit (p = 0.001). 
Conclusions. Angina and ambulatory ECG ischemia re re- 
lieved in a high proportion of patients early after revasculariza- 
tion. However, ischemia can still be induced on the treadmill 
exercise test, albeit at higher levels of exercise, in many patients. 
Bypass urgery was superior to coronary angioplasty in suppress- 
ing cardiac ischemia despite the finding that patients who under- 
went bypass urgery had more severe coronary artery disease. 
(J Am CoU Cardiol 1995;26:606-14) 
Silent myocardial ischemia is frequent in patients with docu- 
mented coronary artery disease. Approximately 33% of 
asymptomatic patients and 50% of patients with angina have 
episodes of silent ischemia during ambulatory electrocardio- 
graphic (ECG) monitoring (1-3). In symptomatic patients with 
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episodes of ambulatory ischemia, silent ischemic episodes 
outnumber the painful episodes by at least hree to one. There 
is also recent evidence that asymptomatic myocardial ischemia 
detected by ambulatory ECG monitoring or exercise testing is 
associated with an adverse prognosis (4-8). Both medical 
therapy with beta-adrenergic blocking agents, calcium antago- 
nists and long-acting nitrates and myocardial revascularization 
have been shown to suppress ilent myocardial ischemia in a 
substantial number of patients (9,10). However, whether isch- 
emia suppression improves prognosis in these patients remains 
to be demonstrated and can be achieved only within the 
framework of large controlled clinical trials. 
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study 
(11) showed that myocardial revascularization by means of 
coronary angioplasty or coronary artery bypass graft surgery 
was significantly more effective than either angina-guided or
angina plus ischemia-guided medical strategy in the allevia- 
tion of silent myocardial ischemia. In patients randomized to 
undergo revascularization, the choice of the procedure was left 
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to the patient and treating physician on the basis of coronary 
anatomy and other practical considerations. Although the 
ACIP design does not provide a randomized comparison of the 
effects of these procedures, the comparisons of observations 
made in patients according to procedure selected are of 
interest. This report compares the relative efficacy and safety 
of coronary angioplasty and coronary artery bypass graft 
surgery in the treatment of myocardial ischemia detected by 
ambulatory ECG monitoring and by treadmill exercise testing 
2 to 3 months after revascularization in the ACIP study. 
Methods  
Study design. Details of the ACIP study design have been 
described previously (12,13). Briefly, the study was initiated to 
compare the safety and efficacy of three randomly assigned 
strategies to suppress i chemia nd to assess the feasibility of a 
larger trial comparing the effects of treatment on prognosis. 
The three treatment strategies included 1) angina-guided 
medical strategy with titration of medication to relieve symp- 
toms; 2) ischemia-guided medical strategy with titration of 
medication to eliminate both angina and ambulatory ECG 
ischemia; and 3) revascularization f all important stenoses in 
major coronary arteries. 
A total of 558 patients were enrolled from October 23, 1991 
to February 1, 1993. Entry criteria included angiographic 
evidence of coronary artery disease with stenoses suitable for 
revascularization, an abnormal stress test and at least one 
episode of asymptomatic 1-mm ST segment depression for at 
least 1 rain on a 48-h ambulatory ECG. 
The primary end point of the study was the effect of therapy 
on cardiac ischemia s detected by the 48-h ambulatory ECG 
at the 12-week visit. Other end points included other measure- 
ments related to ischemia from the 48-h ambulatory ECG, 
ACIP protocol treadmill exercise test and clinical outcomes. 
Revascularization strategy. To be eligible for the ACIP 
study, all patients had to be suitable for revascularization by
either coronary angioplasty or coronary artery bypass graft 
surgery. They were randomly assigned either to a revascular- 
ization strategy or to one of the two medical treatment 
strategies. Patients assigned to the revascularization strategy 
were to undergo either coronary angioplasty or bypass urgery 
within 4 weeks (6 weeks if staged angioplasty was performed) 
of the randomization visit. 
The goal was to achieve revascularization f all important 
stenoses in major coronary arteries. The choice of coronary 
angioplasty or bypass urgery was made by the physician and 
patient and was based on the results of coronary angiography 
usually performed within 2 months of revascularization. I  
general, bypass urgery was considered for patients with mul- 
tivessel disease and coronary angioplasty for patients with 
single- or multivessel disease when the important lesions in 
major coronary arteries were suitable for angioplasty. 
Bypass urgery. Angiographic haracteristics making bypass 
surgery preferable were diffuse coronary disease with lesions 
>20 mm in length, excessive tortuosity or angulation of the 
involved artery, occluded arteries, inability to protect major 
side branches and lesions located so that abrupt vessel closure 
would result in high risk of cardiogenic shock (14). 
Angioplasty. The patient was considered suitable for angio- 
plasty if the lesions satisfied previously established guidelines 
(15,16). The immediate outcome of the intervention was 
classified as successful by the clinical unit staff if all attempted 
stenoses in major coronary arteries were reduced to <50% 
lumen diameter as measured by electronic alipers and the 
patient was free of procedure-related complications, uch as 
death, myocardial infarction or emergency coronary artery 
bypass graft surgery. Anatomic success was defined by the 
Angiography Core Laboratory as a postangioplasty stenosis 
<50% for any or all lesions attempted. 
Medical therapy after revascularization was based on local 
clinical practice. The patient's management of angina after 
revascularization was changed to the ACIP regimen (atenolol/ 
nifedipine or diltiazem/isosorbide initrate), either assigned 
randomly or chosen by the clinical investigator (11-13). 
Follow-up at 12-week visit. All follow-up investigations 
were done -12 weeks (84 to 182 days) after enrollment (i.e., 
-8  weeks after revascularization). They included a 48-h am- 
bulatory ECG, ACIP treadmill exercise test, evaluation of 
anginal status and documentation f clinical outcomes for 
patients who died, had myocardial infarction or underwent 
repeat revascularization. 
At week 12, vital status and documentation f clinical 
events (myocardial infarction or repeat revascularization) were 
obtained for all 558 patients; however, anginal status could not 
be assessed in i bypass urgery group patient. The ambulatory 
ECG results were not available at week 12 for eight angioplasty 
group patients (three refused; two were unwilling or unable to 
report within the time window; two experienced technical 
problems; and one had a cardiac ontraindication) and four 
bypass surgery group patients (one refused; and three had 
postoperative contraindications). The ACIP treadmill exercise 
test was not performed or was not interpretable atweek 12 in 
eight angioplasty group patients (three refused; one had an 
alternate stress test at qualifying visit; one was unwilling or 
unable to report within the time window; two had cardiac 
contraindications; and one had an uninterpretable test) and 
seven bypass urgery group patients (one refused; three had 
uninterpretable tests; and three had cardiac or physical con- 
traindications). 
Statistical methods. Statistical analyses of categorical data 
were performed using the Fisher exact est or chi-square test, 
and analyses of continuous data were performed using the 
Student t test. The Wilcoxon rank-sum statistic was used for 
testing the distributions of ambulatory ECG episodes. The 
percent of patients with ischemic ST segment depression 
during the initial 10 rain of the exercise test was estimated 
using the Kaplan-Meier method (17); patients who did not 
complete 10 rain of exercise for reasons other than ST segment 
depression were censored without he event at the time the test 
was stopped. This analytic method was also used to estimate 
the time to onset of ->l-ram ST segment depression. 
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Figure 1. Schematic showing treatment actually 
received in 192 patients randomly assigned to 
revascularization in the ACIP study. 
To take account of the many hypotheses tested in the ACIP 
study, in secondary analyses p = 0.01 was regarded as showing 
some evidence against he null hypothesis, and p = 0.001 was 
regarded as strong evidence. 
All data processed in the clinical coordinating center as of 
January 18, 1995 were included in these analyses. 
Resu l ts  
Patients. Data reported here are for 558 patients (all 60 
patients from one clinical unit have been excluded, as reported 
by Conti et al. [18]). Of the 192 patients randomly assigned to 
revascularization in the ACIP study, coronary angioplasty was 
judged to be the most appropriate procedure in 102 patients 
and bypass urgery in 90. However, after andom assignment to
revascularization, 8 patients assigned to coronary angioplasty 
and 11 to bypass surgery did not undergo the procedure 
because of subsequent patient or physician refusal. Coronary 
angioplasty was attempted in 94 patients (49%) and bypass 
surgery in 79 (41%); 19 patients (10%) did not undergo any 
revascularization procedure. Three patients (two in the angio- 
plasty group, one in the bypass urgery group) underwent their 
procedures after the 12-week visit and were excluded from the 
analysis. Thus, this report is based on 92 patients in whom 
coronary angioplasty was attempted and 78 patients in whom 
bypass urgery was performed (Fig. 1). 
The median umber of days from study entry to angioplasty 
was 18 and to bypass urgery 32. 
Baseline characteristics. The baseline characteristics of 
the coronary angioplasty and bypass urgery groups are shown 
in Table 1. Patients undergoing bypass surgery had more 
angina (p = 0.001) and more multivessel disease (p = 0.001) 
than those treated with angioplasty. 
Ischemia on the qualifying 48-h ambulatory ECG was also 
more frequent in patients elected for bypass surgery than 
coronary angioplasty. Five or more ischemic episodes on the 
48-h ambulatory ECG were recorded in 56% of the bypass 
surgery group versus 32% of the angioplasty group (compari- 
son of distribution, p : 0.006). The median number of 
ischemic episodes/48 h was five in the bypass urgery group 
versus three in the angioplas~ group (p < 0.001) (Table 2). 
The qualifying ACIP treadmill exercise test was interpret- 
able in 91 patients undergoing coronary angioplasty and in 77 
undergoing bypass urgery (Table 3). The percent of patients 
with -> 1-mm ST segment depression was similar in both groups 
(98% for bypass urgery vs. 95% for coronary angioplasty). 
However, exercise-induced angina was significantly more fre- 
quent in the bypass surgery group than in the coronary 
angioplasty group (80% vs. 49%) (p < 0.001) (Table 3). 
Ambulatory ECG results at 12-week visit. The number of 
patients who were free of ischemia on the 48-h ambulatory 
ECG or events (death, myocardial infarction, coronary angio- 
plasty or bypass urgery) at the 12-week visit was different in 
the two groups (Table 2). Overall, 70% of patients after bypass 
surgery versus 46% after coronary angioplasty were free of 
Table 1. Baseline Characteristics 
PTCA CABG 
(n = 92) (n = 78) 
No. % No. % p Value 
Age _>60 yr 55 60 43 55 
Male gender 72 78 66 85 
Angina present 54 59 67 86 0.001 
Prior M1 36 39 36 46 
Diabetes 16 17 10 13 
Hypertension 36 39 31 40 
Current smoker l I 12 9 12 
Ever smoked 53 58 41 53 
Prior PTCA 20 22 9 12 
Prior CABG 4 4 5 6 
No. of arteries with stenosis ~>50% 
1 35 38 I I  14 
2 42 46 32 41 
3 15 16 35 45 < 0.001 
Ejection fraction 
<35% 2 2 1 1 
35-49% 4 5 12 16 
->50% 77 93 61 82 
Not available 9 4 
Only p < 0.10 is reported. Data presented are number and percent of 
patients. CABG = coronary artery bypass graft surgery; MI = myocardial 
infarction; PTCA = percutaneous transluminal coronary angioplasty. 
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Table 2. Results of Ambulatory  Electrocardiography 
Qualifying Visit Week 12 Visit 
PTCA CABG p Value PTCA CABG p Value 
AECG results available 92 78 
No. of ischemic episodes 
0 - -  - -  
1 20 (22) 7 (9) 
2 23 (25) 10 (13) 
3 9 (10) 10 (13) 
4 11 (12) 7 (9) 
>5 29 (32) 44 (56) 
Event (see Table 6) - -  - -  
25th percentile 2 3 
Median 3 5 
75th percentile 5 8 
Total AECG ischemic time (±in) 
25th percentile 9 12 
Median 21 28 
75th percentile 52 63 
Heart rate (beats/±in) 74.0 + 9.8 74.6 + 10.4 
Maximal heart rate (beats/min) 130.5 + 16.1 130.0 _~ 18.5 
Maximal ST segment depression 2.0 _+ 0.9 2.2 ± 1.2 
× Total ischemic time 76.5 +_ 104.1 95.1 + 139.5 
0.006 
<0.001 
84 74 
39 (46) 52 (70) 
11 (13) 7 (10) 
8 (9) 4 (5) 
6 (7) 0 (0) 
2 (2) 1 (1) 
12 (14) 9 (12) 
7 (8) 1 (1) 
0 0 
0 0 
2 1 
0 0 
0 0 
15 4 
70.2 ± 10.4 79.3 ± 12.1 
121.5 ± 16.1 130.5 + 20.3 
0.9 _+ 1.1 0.5 + 0.8 
29.3 _+ 73.2 16.4 + 38.7 
0.02 
< 0.001 
0.002 
0.003 
Only p < 0.10 is reported. Data presented are number (%) of patients or mean value .+ SD. AECG = ambulatory electrocardiographic; other abbreviations as in 
Table l. 
ambulatory ischemia or events at the 12-week visit (p = 0.002) 
(Fig. 2). 
Treadmill exercise test results at 12-week visit. ST seg- 
ment depression ->1 mm was no longer present in 46% of 
patients after bypass urgery versus 23% after angioplasty (p = 
0.005) (Table 3). Exercise-induced angina was no longer 
present at the 12-week visit in 90% of the bypass surgery group 
versus 70% of the angioplasty group (p = 0.01) (Fig. 3). In 
patients who performed the ACIP treadmill test at both 
qualifying and 12-week visits, total exercise time increased by 
2.4 min after bypass surgery and by 1.4 ±in after angioplasty 
(p = 0.02); time to l-ram ST segment depression increased by 
3.7 min after bypass surgery and by 1.7 min after angioplasty. 
The number of abnormal exercise ECG leads at the 12-week 
visit was 1.7 in the surgery group versus 3.1 in the angioplasty 
group (p < 0.001). Maximal ST depression at the 12-week visit 
was 0.9 mm after bypass surgery versus 1.7 mm after angio- 
plasty (p < 0.001). The sum of ST segment depression at the 
12-week visit was 3.6 mm after bypass surgery versus 7.0 mm 
after angioplasty (p < 0.001). 
Angina status at 12-week visit. Stable angina, defined as 
any angina during the past 4 weeks, was present at the 12-week 
Table 3. Treadmil l  Exercise Test Results 
Qualifying Visit Week 12 Visit 
PTCA CABG p Value PTCA CABG p Value 
ETT data interpretable 91 77 84 71 
-> l -m± ST segment depression* 84 (95) 72 (98) 56 (77) 31 (54) 0.005 
Exercise-induced angina* 33 (49) 51 (80) < 0.001 21 (30) 6 (10) 0.01 
Total exercise time (min) 7.2 z 3.2 6.3 __ 2.9 8.6 +_ 3.4 8.5 ± 3.6 
% of age-predicted maximal heart rate 86.5 ± 11.3 81.2 ~ 12.0 0.009 85.4 _+ 13.5 93.1 ± 12.0 < 0.001 
Time to l -m± ST depression (min [mean _+SE])t 4.8 .+ 0.3 3.9 m 0.2 6.5 ± 0.3 7.6 ± 0.3 
No. of exercise ECG leads with abnormal findings 4.4 + 1.8 4.4 ~ 2.0 3.1 ± 2.4 1.7 + 2.2 < 0.001 
Maximal ST segment depression 2.4 ± 0.9 2.6 ± 1.3 1.7 ± 1.3 0.9 ± 1.1 < 0.001 
Sum of ST segment depression in leads with abnormal findings 9.5 _+ 4.7 10.4 ± 5.8 7.0 ± 5.8 3.6 ± 4.4 < 0.001 
Maximal heart rate (beats/±in) 137.5 + 17.9 128.7 ± 17.9 0.002 135.9 + 21.4 147.7 ± 18.9 < 0.001 
Maximal systolic blood pressure (mm Hg) 177.2 ± 27.5 169.1 .+ 24.7 177.8 + 24.3 179.5 ± 27.3 
*Kaplan-Meier life-table analysis used to calculate percent of patients with specified event during first 10 ±in of exercise; occurrences after 10 min or during 
recovery are not counted, tKaplan-Meier life-table analysis used to estimate mean time to event during first 10 ±in of exercise; occurrences after 10 min or during 
recovery are not counted. If event rates are <50%, mean and median values are not available. Only p < 0.10 is reported. Data presented are number (%) of patients 
or mean value + SD, unless otherwise indicated. ECG = electrocardiogram; EFT = treadmill exercise test; other abbreviations as in Table 1. 
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Figure 2. Patients without ischemia on the ambulatory electrocardio- 
gram or events at 12 weeks. Ambulatory cardiac ischemia was sup- 
pressed in 46% of patients after coronary angioplasty versus 70% of 
patients after coronary artery bypass graft surgery (p = 0.002). 
visit in 32% of patients after angioplasty but in only 10% of 
patients after bypass surgery (p = 0.001) (Table 4, Fig. 4). 
Angina was mild to moderate (Canadian Cardiovascular Soci- 
ety class I or II) in all but one patient in the coronary 
angioplasty group. No patient experienced unstable angina 
before the 12-week visit. 
Adjunctive medical therapy at 12-week visit. The percent 
of patients who were taking study medication (background or 
open label to relieve angina at the 12-week visit) was 49% after 
angioplasty and 10% after bypass surgery. The percent of 
patients taking one drug was 36% and 10%, respectively. The 
percent of patients taking two drugs was 13% and 0%, 
respectively. 
Revascularization strategy and outcome. Coronary angio- 
plasty was performed in 86 of the 92 patients in whom it was 
attempted (Table 5). It was not performed in six patients 
because of inability to cross the lesion. By clinical unit assess- 
Figure 3. Patients without ischemia or angina on the ACIP treadmill 
exercise test at the 12-week visit (-8 weeks after evascularization). At 
the 12-week visit, -1 mm ST segment depression was no longer 
present in 23% of patients after coronary angioplasty versus 46% after 
bypass urgery (p -- 0.005). Exercise-induced angina was absent in 
70% of patients after coronary angioplasty versus 90% after bypass 
surgery (p = 0.01). 
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Table 4. Angina Status at 12-Week Visit 
PTCA CABG p 
[no. (%) of pts] [no. (%) of pts] Value 
Angina data available 92 77 
Canadian Cardiovascular 
Society classification 
None 63 (69) 69 (90) 
I 14 (15) 4 (5) 
II 14 (15) 4 (5) 
IH 1 (1) 0 (0) 
iv o (o) o (o) O.Ol 
Only p < 0.10 is reported, pts = patients; other abbreviations as in Table 1. 
ment, the procedure was successful in 76 patients (83%). 
Angiography core laboratory assessment of anatomic success 
was 82% when defined as postangioplasty stenosis <50% for 
any lesion attempted and 78% for all lesions attempted. One 
lesion was dilated in 73% of patients, two in 23% and three in 
4%. One vessel was dilated in 89% of patients and two vessels 
in 11%. Core laboratory assessment of complete revascular- 
ization, defined as all significant stenoses reduced to <50% 
diameter stenosis, was achieved in 29 patients (32%). 
Bypass urgery was performed before the 12-week visit in 78 
patients. The mean number of grafts placed was three. The 
number of bypass grafts matched or exceeded that of diseased 
major coronary arteries in 74 (95%) of the 78 patients. Internal 
thoracic artery grafts were used in 66 patients (85%). Fifty-five 
patients had one and 11 patients had two internal thoracic 
artery grafts. One patient had another arterial graft. 
Within 24 h of coronary angioplasty, there were three 
events in two patients (nonfatal myocardial infarction and 
bypass urgery in one, emergency bypass urgery in the other). 
There were no deaths and no myocardial infarctions in the 24 h 
after bypass surgery. Five patients had other complications 
(stroke followed by recovery with no residual neurologic 
impairment in one, reoperation for bleeding in four). 
By 84 days, only one patient had had an event (myocardial 
infarction) in the bypass surgery group, whereas seven had 
Figure 4. Patients without angina at the 12-week visit. Angina in the 
4-week period before the 12-week visit was absent in 68% of patients 
after coronary, angioplasty versus 90% after bypass urgery (p = 0.001). 
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Table 5. Outcome After Coronary Angioplasty 
PTCA (n = 92) 
No. % 
Performed 86 
Attempted but not performed because of 6 
inabili~' to cross lesion 
Outcome (clinical unit assessment) 
Successful 76 83 
Not successful (includes attempts) 16 17 
No. of lesions dilated (angiography core 
laboratory eview) 
1 67 73 
2 21 23 
3 4 4 
Anatomic success 
Any lesion attempted 75 82 
All lesions attempted 72 78 
Data presented are number and percent of patients. PTCA - percutaneous 
transluminal coronary angioplasty. 
events (myocardial infarction in three, repeat angioplasty in 
two, bypass urgery in four) in the coronary angioplasty group 
(Table 6). Repeat coronary angioplasty after the index proce- 
dure was performed because of unstable angina after abrupt 
vessel closure in one patient and because of severe ischemia 
on the treadmill exercise test in another. The reasons for 
nonprotocol coronary artery bypass graft surgery included 
failed coronary angioplasty in four patients and unstable 
angina in one. 
Discuss ion  
Rationale for assessing revascularization by treatment 
received. The results of the ACIP study showed that myocar- 
dial revascularization was superior to medical therapy in 
reducing ischemia on the 48-h ambulatory ECG at the 12-week 
visit (11). The percent of patients who were ischemia free was 
similar for both angina-guided and angina plus ischemia- 
guided medical strategies, but more patients in the revascular- 
ization strategy were ischemia free on the 12-week ambulatory 
ECG than in the other two groups. The treadmill exercise test 
results at the 12-week visit were concordant with those of 
ambulatory ECG monitoring. All three treatment strategies 
improved exercise tolerance and reduced exercise-induced 
angina and exercise-induced ECG evidence of ischemia. The 
results of the two medical strategies were comparable, and the 
revascularization strategy was more effective than either med- 
ical strategy in increasing total exercise time and decreasing 
the percent of patients with exercise-induced angina and ST 
segment depression (11). 
The effect of the three treatment strategies in the ACIP 
study was analyzed according to treatment assignment. Thus, 
all patients randomly assigned to revascularization were in- 
cluded in the analysis. Even though analysis of the revascular- 
ization by treatment received was not specified in the ACIP 
protocol, and therefore the conclusions of this post hoc 
analysis are less definitive than those of the main ACIP results, 
further analysis of patients assigned to revascularization strat- 
egy according to treatment received is of interest. 
1) As observed in previous trials involving myocardial 
revascularization (19), not all patients who were assigned to 
revascularization i  the ACIP study underwent coronary an- 
gioplasty or bypass surgery. A total of 19 patients did not 
undergo any revascularization procedure because of patient or 
physician refusal or preference or for other logistic reasons, 
and 3 patients underwent he procedure after the 12-week 
follow-up visit. This high noncompliance rate is probably not 
unusual in patients who, although they had severe coronary 
artery disease, had few or no symptoms. These 22 patients 
were receiving medical therapy when the 12-week 48-h ambu- 
latory ECG, ACIP protocol treadmill exercise test and clinical 
outcome data were analyzed. 
2) To our knowledge, the relative efficacy and safety of 
coronary angioplasty and bypass surgery in relieving cardiac 
ischemia in patients with severe coronary artery disease has not 
previously been assessed prospectively. Bypass surgery is ex- 
pected to be more effective than coronary angioplasty in 
patients with multivessel disease, mainly because it usually 
results in more complete revascularization. Revascularization 
may be incomplete after coronary angioplasty in patients with 
multivessel coronary artery disease: One or more significant 
lesions may not be successfully dilated; complete revascular- 
ization may be intended but not attempted because of proce- 
Table 6. Events and Procedures by 84 Days 
PTCA 
(n 92) 
CABG 
(n = 78) 
Event or Procedure No. % No. % p Value 
Death 0 0 0 0 
MI 3 3 1 1 
Death or MI 3 3 1 1 
PTCA 2 2 0 0 
CABG 4 4 0 0 
PTCA or CABG 6 7 0 0 
Any of above 7 8 1 1 
0.03 
Only p < 0.10 is reported. Data presented are number and percent of patients. MI = myocardial nfarction; other 
abbreviations as in Table 1. 
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dural complications. However, in most cases, incomplete re- 
vascularization is part of a preferred coronary angioplasty 
strategy, and it can be anticipated before the procedure. 
Complete revascularization may not be planned for clinical 
reasons, which include, among others, unstable angina, recent 
myocardial infarction, severe left ventricular dysfunction and 
other urgent/emergent problems arising during coronary an- 
gioplasty. Complete correction may not be possible in patients 
with chronic total occlusions or adverse stenosis morphology or 
may not be planned in patients with less than severe coronary 
narrowing (20). 
3) Restenosis of one or more lesions occurs frequently 
between 1 and 4 months after coronary, angioplasty and 
contributes to recurrence of ischemia in patients with single- 
and multivessel disease. 
Relative efficacy and safety of coronary angioplasty and 
bypass surgery. Previous studies (21-25) have shown that 
cardiac ischemia on the ambulatory ECG or the treadmill 
exercise test, or both, is frequently abolished after revascular- 
ization by either coronary angioplasty or coronary artery 
bypass graft surgery. However, the relative efficacy and safety 
of each procedure in suppressing cardiac ischemia have not 
been adequately studied. Moreover, it has not yet been clearly 
established whether ischemia suppression is dependent on 
completeness of revascularization (21,24) and whether isch- 
emia suppression after myocardial revascularization influences 
long-term prognosis (22-24). 
Among patients randomly assigned to revascularization in 
the ACIP study, those in whom coronary artery bypass graft 
surgery was selected and performed were higher isk patients 
than those undergoing coronary angioplasty. They had more 
angina, and more had a history of previous myocardial infarc- 
tion, more severe coronary artery disease and left ventricular 
dysfunction. They also had evidence of more ischemia on the 
prerandomization 48-h ambulatory ECG and lower exercise 
tolerance and more ischemia on the baseline ACIP treadmill 
test. The ACIP results howed that despite these differences in
baseline characteristics, a much higher percent of patients 
were ischemia free on the 48-h ambulatory ECG at the 
12-week visit (-8 weeks after revascularization) after bypass 
surgery than after coronary angioplasty. Overall, 70% of 
patients were ischemia free after bypass urgery compared with 
46% after coronary angioplasty. Bypass urgery was by far the 
most effective treatment in reducing myocardial ischemia in 
the ACIP study. Coronary angioplasty was not significantly 
better than medical therapy alone, where -40% of patients 
were ischemia free on the 48-h ambulatory ECG at the 
12-week visit (11). 
Angina pectoris within the past 4 weeks was relieved in 90~: 
of patients after bypass urgery, whereas itwas relieved in 68% 
after coronary angioplasty. These clinical benefits are in agree- 
ment with the relative efficacy of each revascularization pro- 
cedure on suppression of ambulatory ECG ischemia in this 
study. They are also consistent with previous reports on clinical 
effectiveness of these interventions (26,27). 
Cardiac events and repeat revascularization procedures 
through 12 weeks were more frequent after angioplasty than 
after bypass urgery. Only one surgical patient had an event 
before 12 weeks compared with seven angioplasty patients. 
Suppression of ambulatory and exercise-induced ischemia 
follow-up results differed in the ACIP study. After bypass 
surgery, ambulatory ECG ST segment depression persisted at 
12 weeks in only 30% of patients, whereas exercise-induced ST 
segment depression persisted in 54%. Likewise, after coronary 
angioplasty, ambulatory ECG ST segment depression was 
present at 12 weeks in 54% of patients, whereas exercise- 
induced ST segment depression was present in 77%. However, 
exercise-induced ischemia occurred at a higher work load after 
revascularization. Patients were able to exercise an average of 
3.7 min longer after bypass urgery and an average of 1.7 rain 
longer after angioplasty before onset of ST segment depres- 
sion. Nevertheless, these results suggest that some degree of 
residual ischemia persists in many patients after revasculariza- 
tion and that even after coronary artery bypass graft surgery, 
restoration of blood supply may be incomplete. 
Influence of completeness of revascularization. The ACIP 
protocol was not designed to assess completeness of revascu- 
larization after either coronary angioplasty or bypass urgery. 
Multivessel disease was present in 86% of patients undergoing 
bypass urgery. The average number of grafts in these patients 
was three, and the number of grafts matched or exceeded the 
number of diseased major coronary arteries in 95% of patients. 
In addition, 85% of patients received one or more internal 
thoracic artery grafts. 
Multivessel disease was present in 62% of patients under- 
going coronary angioplasty. The procedure was successful; that 
is, all attempted stenoses in the major coronary arteries were 
reduced to <50% diameter without procedure-related compli- 
cations in 83% of patients. However, angioplasty of only one 
lesion was attempted in 73% of patients and only one vessel in 
89%. Complete revascularization was achieved in only 32% of 
the patients. These procedures were performed at major 
academic enters with the specific goal of achieving revascu- 
larization of all important stenoses in major coronary arteries. 
Thus, it can be assumed that this outcome is representative of
current clinical practice. Comparison with data in published 
reports of coronary angioplasty in patients with multivessel 
disease supports this assumption (20). 
Recent trials comparing coronary angioplasty and bypass 
surgery. Four prospective randomized trials comparing the 
relative efficacy and safety of coronary angioplasty and 
bypass urgery in patients with symptomatic coronary artery 
disease have been published recently (28-31). There are 
major differences in patient selection and study design 
between the ACIP study and these recent rials. In the ACIP 
study, the patients had to be suitable for revascularization 
by only one procedure, although they were randomly as- 
signed to revascularization, and the choice of the revascu- 
larization procedure was made by the clinical site physician 
and patient on the basis of coronary anatomy and other 
clinical considerations. In the other studies, the patients had 
to be suitable for equivalent revascularization with either 
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angioplasty or bypass surgery, and they were randomly 
assigned to one or the other procedure. Thus, the anatomic 
characteristics were different, and the patients in these other 
studies may be viewed as having anatomic characteristics 
present only in the subset of ACIP patients who would be 
suitable for equivalent revascularization by either proce- 
dure. These anatomic differences resulted in the finding that 
complete or optimal revascularization was more consistently 
attempted and achieved after angioplasty in these studies 
than in the ACIP study. Finally, the primary end points of 
these studies were clinical events at 1 to 3 years after 
revascularization, whereas the primary end point of the 
ACIP study was suppression of ambulatory ischemia at 3 
months. 
These studies suggested that, as a rule, both coronary 
angioplasty and bypass surgery resulted in a similar clinical 
outcome, including similar mortality and myocardial infarction 
1 to 3 years after enrollment. However, nonprotocol repeat 
revascularization was fourfold to tenfold more frequent after 
coronary angioplasty than after bypass surgery. When this 
higher frequency of nonprotocol revascularization after angio- 
plasty was taken into account, angina was relieved in most 
cases with both procedures, and, in the Emory Angioplasty 
versus Surgery Trial (31), residual ischemia on the thallium- 
201 perfusion scan was similar at 3 years in both treatment 
groups. If one assumes that nonprotocol repeat revasculariza- 
tion was a marker for persistent ischemia after the index 
revascularization i  these studies, their results are concordant 
with those of the ACIP study. Whether clinical events are also 
less frequent after bypass surgery than after angioplasty, when 
the ACIP revascularization strategy, which is more in line with 
the usual clinical practice, is followed is not known. The effect 
of the revascularization practice used in the ACIP study on 
1-year clinical outcome should be available shortly and will be 
of considerable interest. However, the full answer to the 
question of frequency of postrevascularization clinical events 
will require a larger long-term prognosis tudy using the ACIP 
protocol 
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